tiprankstipranks
Advertisement
Advertisement

OVID Stock Latest News

Ovid Therapeutics files to sell 29.86M shares of common stock for holders
The FlyOvid Therapeutics files to sell 29.86M shares of common stock for holders
11d ago
OVID
Ovid Therapeutics Boosts Capital Through Warrant Exercises
PremiumCompany Announcements
Ovid Therapeutics Boosts Capital Through Warrant Exercises
13d ago
8K
OVID
Ovid Therapeutics: Differentiated KCC2 ‘Master Switch’ Platform and Strong Cash Runway Underpin Buy Rating
PremiumRatings
Ovid Therapeutics: Differentiated KCC2 ‘Master Switch’ Platform and Strong Cash Runway Underpin Buy Rating
18d ago
OVID
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
PremiumRatings
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
24d ago
OVID
Ovid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
24d ago
OVID
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
25d ago
IVA
OVID
Ovid Therapeutics price target raised to $7 from $5 at Wedbush
Premium
The Fly
Ovid Therapeutics price target raised to $7 from $5 at Wedbush
1M ago
OVID
Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines
Premium
Company Announcements
Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines
1M ago
OVID
Ovid Therapeutics price target raised to $5 from $3 at Roth Capital
PremiumThe Fly
Ovid Therapeutics price target raised to $5 from $3 at Roth Capital
1M ago
OVID
Ovid Therapeutics: Advancing OV329 Pipeline, De‑Risked Differentiation, and Strong Cash Runway Support Buy Rating
PremiumRatings
Ovid Therapeutics: Advancing OV329 Pipeline, De‑Risked Differentiation, and Strong Cash Runway Support Buy Rating
1M ago
OVID
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
PremiumThe Fly
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
2M ago
M
CF
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
PremiumTipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
2M ago
CING
OVID
Ovid Therapeutics Raises Capital to Expand Epilepsy Pipeline
PremiumCompany AnnouncementsOvid Therapeutics Raises Capital to Expand Epilepsy Pipeline
2M ago
8K
OVID
Ovid Therapeutics announces Phase 1 clearance for OV4071
Premium
The Fly
Ovid Therapeutics announces Phase 1 clearance for OV4071
2M ago
OVID
Ovid Therapeutics reports Q4 EPS 6c, consensus (10c)
Premium
The Fly
Ovid Therapeutics reports Q4 EPS 6c, consensus (10c)
2M ago
OVID
Ovid Therapeutics sees cash runway into late 2028
PremiumThe Fly
Ovid Therapeutics sees cash runway into late 2028
2M ago
OVID
Ovid Therapeutics announces OV239 data, indication expansion
PremiumThe Fly
Ovid Therapeutics announces OV239 data, indication expansion
2M ago
OVID
Ovid Therapeutics prices 19.15M shares at $2.01 in private placement
PremiumThe Fly
Ovid Therapeutics prices 19.15M shares at $2.01 in private placement
2M ago
OVID
OVID Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OVID Earnings this Week: How Will it Perform?
2M ago
OVID
CWAN, HTBK, OVID, MCFT, WHWK Trending With Analysts
PremiumWeekend UpdatesCWAN, HTBK, OVID, MCFT, WHWK Trending With Analysts
4M ago
CWAN
HTBK
Ovid Therapeutics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Ovid Therapeutics initiated with an Outperform at LifeSci Capital
4M ago
OVID
Ovid Therapeutics: Positive KCC2 Platform Progress and Underappreciated Pipeline Optionality Support Reiterated Buy Rating
Premium
Ratings
Ovid Therapeutics: Positive KCC2 Platform Progress and Underappreciated Pipeline Optionality Support Reiterated Buy Rating
4M ago
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >